期刊文献+

肾小球足突细胞黏蛋白,肿瘤内皮标记物-8,血管内皮生长因子D在结、直肠癌中的表达及意义

Expression of Podoplanin,TEM-8 and VEGF-D in Colorectal Cancer and Significance
下载PDF
导出
摘要 目的:分析肾小球足突细胞黏蛋白(Podoplanin),肿瘤内皮标记物-8(TEM-8),血管内皮生长因子D(VEGF-D)在结、直肠癌中的表达及其意义。方法:用实时定量PCR方法分析30结、肠癌标本中TEM-8,Podoplanin及VEGF-D的表达,并结合病理学分期,淋巴结转移等肿瘤特点进行分析。结果:Podoplanin在肿瘤组织中的表达较正常组织中高,并与淋巴结转移及肿瘤分期相关;VEGF-D在肿瘤组织中的表达较正常组织中高,并与淋巴结转移相关,而与肿瘤分期无明显相关性;TEM-8在正常组织中基本无阳性表达,而在结、直肠癌组织中阳性表达率为90%,与肿瘤分期,淋巴结转移相关。结论:TEM-8,Podoplanin,VEGF-D均可作为结、直肠癌的标记物,并可反映淋巴结转移状况,TEM-8更可作为肿瘤特异性标记物,在结、直肠癌的诊断、治疗、预后判断中可望发挥重要作用。 OBJECTIVE: To analyze the expression of Podoplanin, TEM-8 and VEGF-D in coloreetal cancer as well as its significance. METHODS: The expression of Podoplanin, TEM-8 and VEGF-D in coloreetal cancer specimens obtained from 30 colorectal cancer patients was analyzed using RT-PCR combining the characteristics of tumor in pathological staging and rnetastasizing of lymph nodes etc. RESULTS: Podoplanin level was higher in the tumor tissues than in normal tissues, and it was related to both lyrnphnode metastasis and tumor stage; VEGF-D level were higher in tumor tissues than in normal tissues, and it was related with lymphnode metastasis but independent of tumor stage. However, TEM-8 was negatively expressed in normal tissues, but its expression rate in colorectal cancer tissues reached 90% , and it was related to both tumor stage and lyrnphnode metastasis. CONCLUSION: Podoplanin, VEGF-D and TEM-8 can act as tumor markers for colorectal cancer and a predictor of lymph node metastasis, as well as a tumor specific marker, and which are expected to play an important role in the diagnosis, prognostic prediction and treatment of colorectal cancer.
出处 《中国医院用药评价与分析》 2008年第4期284-286,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 直肠癌 PODOPLANIN TEM-8 VEGF-D Colorectal cancer Podoplanin TEM-8 VEGF-D
  • 相关文献

参考文献2

二级参考文献25

  • 1钱隼南.从分子学角度看肿瘤细胞侵袭和转移[J].国外医学(肿瘤学分册),1994,21(2):95-97. 被引量:6
  • 2Rmall KA, A1-Rawi'IVIA, Parr C, Puntis MC, Jiang WG. Upregulation of tumor endothelial marker-8 by interleukin-1 β and its impact in IL-1 β induced angiogenesis. Int J Mol Med 2004; 14:75-80.
  • 3Jiang WG, Watkins G, Lane J, Cunnick GH, Douglas-Jones A, Mokbel K, Mansel RE. Prognostic value of Rho familty and and rho-GDIs in breast cancer. Clin Cancer Res 2003; 9:6432-6440.
  • 4Dukes CE, Bussey HJ. The spread of rectal cancer and its effect on prognosis. Br J Cancer 1958; 12:309-320.
  • 5Chapuis PH, Dent OF, Fisher R, Newland RC, Pheils MT,Smyth E, Colquhoun K. A multivariate analysis of clinical and pathological variables in prognosis after rescetion of large bowel cancer. Br J Cancer 1985; 72:1424-1429.
  • 6Fielding LP, Phillips RK, Fry JS, Hittinger R. Prediction of outcome after curative resection for large bowel cancer. Lancet 1986; 2:904-907.
  • 7Kerbel R, Folkman J. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2002; 2:727-739.
  • 8Folkman J. Tumor angiogenesis: Therapeutic implications.N Engl J Med 1971; 285:1182-1186.
  • 9St Croix B, Rago C, Velculescu V, Traverso G, Romans KE,Montgomery E, Lai A, Riggins GJ, Lengauer C, Vogelstein B,Kinzler KW. Genes expression in human tumor endothelium Science 2000; 289:1197-1201.
  • 10Jiang WG, Douglas-Jones A, Mansel RE. Expression of peroxisome-proliferator activated receptor-gamma (PPARgamma) and the PPARgamma co-activator, PGC-1, in human breast cancer correlates with clinical outcomes. Int J Cancer 2003;106:752-757.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部